Biomarkers in lung cancer

Front Biosci (Elite Ed). 2010 Jun 1;2:1099-104. doi: 10.2741/e168.


Here we review the role of tissutal and circulating biomarkers in the management of lung cancer. In the past they were considerate quite ineffective tools as regards prognosis and prediction of treatment activity, nowadays instead, they are becoming a crucial key point as potential predictive issues in driving therapy, with possibly prognostic values as well.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor / blood*
  • Carcinoma, Non-Small-Cell Lung / blood*
  • Carcinoma, Small Cell / blood*
  • Humans
  • Lung Neoplasms / blood*


  • Biomarkers, Tumor